MUMBAI, India, Oct. 5 -- Intellectual Property India has published a patent application (202521003729 A) filed by Entod Pharmaceuticals Ltd. on January 16, 2025, for An Ophthalmic Formulation And Its Method Of Preparation.
Inventors include Nikkhil K Masurkar; and Bharati S. Jadhav.
The application for the patent was published on October 02, 2026, under issue no. 40/2026.
Abstract: ABSTRACT AN OPHTHALMIC FORMULATION AND ITS METHOD OF PREPARATION The present invention provides an Ophthalmic formulation and its method of preparation. Particularly, the invention provides an Ophthalmic formulation comprising Losartan and its method of preparation. The invention pertains to the development of ophthalmic solutions containing Losartan at specified concentration levels for treating or managing various eye conditions. These solutions are designed for direct administration to the eyes, delivering therapeutic benefits while minimizing systemic exposure. The composition is useful for the treatment of conditions such as glaucoma, diabetic retinopathy, macular edema, or ocular hypertension by exploiting losartan's vascular-modulating and anti-inflammatory properties.
Disclaimer: Curated by HT Syndication.
